biote Statistics
Total Valuation
biote has a market cap or net worth of $133.25 million. The enterprise value is $195.23 million.
Important Dates
The last earnings date was Wednesday, March 12, 2025, after market close.
| Earnings Date | Mar 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 36.71 million shares outstanding. The number of shares has increased by 33.30% in one year.
| Current Share Class | 31.49M |
| Shares Outstanding | 36.71M |
| Shares Change (YoY) | +33.30% |
| Shares Change (QoQ) | +15.59% |
| Owned by Insiders (%) | 28.47% |
| Owned by Institutions (%) | 50.96% |
| Float | 15.54M |
Valuation Ratios
The trailing PE ratio is 40.33 and the forward PE ratio is 9.08.
| PE Ratio | 40.33 |
| Forward PE | 9.08 |
| PS Ratio | 0.58 |
| Forward PS | 0.56 |
| PB Ratio | -1.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.19 |
| P/OCF Ratio | 2.73 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.02, with an EV/FCF ratio of 5.03.
| EV / Earnings | 61.84 |
| EV / Sales | 0.99 |
| EV / EBITDA | 5.02 |
| EV / EBIT | 5.18 |
| EV / FCF | 5.03 |
Financial Position
The company has a current ratio of 1.32
| Current Ratio | 1.32 |
| Quick Ratio | 0.92 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.81 |
| Debt / FCF | 2.86 |
| Interest Coverage | 3.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 16.96% |
| Return on Invested Capital (ROIC) | 54.15% |
| Return on Capital Employed (ROCE) | 53.18% |
| Revenue Per Employee | $908,714 |
| Profits Per Employee | $14,548 |
| Employee Count | 217 |
| Asset Turnover | 1.42 |
| Inventory Turnover | 3.01 |
Taxes
In the past 12 months, biote has paid $970,000 in taxes.
| Income Tax | 970,000 |
| Effective Tax Rate | 95.47% |
Stock Price Statistics
The stock price has decreased by -37.41% in the last 52 weeks. The beta is 1.07, so biote's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | -37.41% |
| 50-Day Moving Average | 4.51 |
| 200-Day Moving Average | 5.83 |
| Relative Strength Index (RSI) | 41.60 |
| Average Volume (20 Days) | 324,710 |
Short Selling Information
The latest short interest is 719,056, so 1.96% of the outstanding shares have been sold short.
| Short Interest | 719,056 |
| Short Previous Month | 651,439 |
| Short % of Shares Out | 1.96% |
| Short % of Float | 4.63% |
| Short Ratio (days to cover) | 2.77 |
Income Statement
In the last 12 months, biote had revenue of $197.19 million and earned $3.16 million in profits. Earnings per share was $0.09.
| Revenue | 197.19M |
| Gross Profit | 139.06M |
| Operating Income | 37.68M |
| Pretax Income | 10.67M |
| Net Income | 3.16M |
| EBITDA | 38.86M |
| EBIT | 37.68M |
| Earnings Per Share (EPS) | $0.09 |
Full Income StatementBalance Sheet
The company has $39.34 million in cash and $110.86 million in debt, giving a net cash position of -$71.52 million or -$1.95 per share.
| Cash & Cash Equivalents | 39.34M |
| Total Debt | 110.86M |
| Net Cash | -71.52M |
| Net Cash Per Share | -$1.95 |
| Equity (Book Value) | -102.20M |
| Book Value Per Share | -3.36 |
| Working Capital | 16.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $45.24 million and capital expenditures -$6.43 million, giving a free cash flow of $38.81 million.
| Operating Cash Flow | 45.24M |
| Capital Expenditures | -6.43M |
| Free Cash Flow | 38.81M |
| FCF Per Share | $1.06 |
Full Cash Flow StatementMargins
Gross margin is 70.52%, with operating and profit margins of 19.11% and 1.60%.
| Gross Margin | 70.52% |
| Operating Margin | 19.11% |
| Pretax Margin | 0.52% |
| Profit Margin | 1.60% |
| EBITDA Margin | 19.70% |
| EBIT Margin | 19.11% |
| FCF Margin | 19.68% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.30% |
| Shareholder Yield | -33.30% |
| Earnings Yield | 2.55% |
| FCF Yield | 31.38% |
Analyst Forecast
The average price target for biote is $8.00, which is 120.39% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 120.39% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 10.26% |
| EPS Growth Forecast (5Y) | 77.62% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 2.14 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.14 |
| Piotroski F-Score | 7 |